<DOC>
	<DOCNO>NCT02980406</DOCNO>
	<brief_summary>In study , investigator aim assess effect acute FODMAP infusion gastric motility gastrointestinal psychological symptom . 20 healthy volunteer 20 patient irritable bowel syndrome ( IBS ) undergo respectively four two/three pressure measurement stomach overnight fast measure gastric motility . During pressure measurement , take approximately 4 hour , one four FODMAP control solution administer directly stomach nasogastric tube . Administration stop participant fully satiate . The four solution test healthy volunteer ( 1 ) fructan solution , ( 2 ) fructose solution , ( 3 ) FODMAP mix ( 4 ) glucose solution control . In IBS patient , fructan glucose solution test , choose come third visit test fructose solution . The solution test separate occasion randomize order . During pressure measurement , participant ask complete several questionnaire : ( 1 ) gastrointestinal symptom questionnaire assess gastrointestinal symptom , ( 2 ) satiation questionnaire infusion one solution , ( 3 ) psychological questionnaire ( POMS , SAM , PANAS STAI ) evaluate possible psychological effect FODMAP infusion . The investigator hypothesize difference gastric motility healthy volunteer IBS patient . Furthermore , hypothesize gastrointestinal symptom increase IBS patient , FODMAP infusion psychological effect patient healthy volunteer .</brief_summary>
	<brief_title>The Role FODMAPs Upper GI Effects , Colonic Motor Activity Gut-brain Signaling Behavioral Level</brief_title>
	<detailed_description>In study , investigator aim assess effect acute FODMAP infusion gastric motility gastrointestinal psychological symptom . This randomised , single-blinded , crossover study different solution , differ FODMAP content . The four solution test healthy volunteer ( 1 ) fructan solution , ( 2 ) fructose solution , ( 3 ) FODMAP mix ( 4 ) glucose solution control . In IBS patient , fructan glucose solution test , choose come third visit test fructose solution . The different solution test separate occasion , three day one week apart , randomise order . The preparation study visit identical . After overnight fast , participant ask come clinic . To ensure low baseline symptom level low microbial gut activity , diet low fibre fermentable carbohydrate follow day prior test ( information provide assist ) . Participants ask refrain alcohol , tea coffee , intense physical activity least 12 hour participation . They also ask refrain smoking cigarette least one hour start experiment . A high resolution manometry probe insert nose stomach participant ass intragastric pressure measure gastric motility gastric accommodation . In addition , infusion tube position proximal stomach administer solution . The position probe check fluoroscopically ( maximum 15 second ) . In case , relevant guideline radioprotection adhere . Patients protected lead shield cover low abdomen personnel wear lead jacket . After catheter fixed subject ' chin , patient ask sit table remain position remainder experiment . After stabilization period least 15 minute , subject phase II hunger cycle , one four solution intragastrically administer constant speed 60 mL per minute ( determine automate system use peristaltic pump ) . IGP record duration drink infusion follow 3 hour . During infusion , subject ask score satiation 1-minute interval use graphic rating scale combine verbal descriptor scale grade 0-5 ( 1 , threshold ; 5 , maximum satiety ) . The intragastric infusion stop soon score 5 reach satiation score . In addition , participant ask complete gastrointestinal symptom questionnaire every 15 minute . The participant 's emotion mood assess , immediately 1 , 2 3 hour infusion , use State-Trait Anxiety Inventory ( STAI ) validate Dutch version Positive Negative Affect Scale ( PANAS ) . Emotional state repeatedly measure every 15 minute use Self-Assessment Manikin ( SAM ) Profile Mood States ( POMS ) -Fatigue subscale .</detailed_description>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Healthy volunteer : Aged 18 65 year old Current symptom history gastrointestinal disease , significant disease , psychological disorder , drug allergy pregnancy Taking medication drug history IBS patient : Meet Rome III criterion IBS . This defined recurrent abdominal pain discomfort least 3 days/month last 3 month associate two follow : improvement defecation ; onset associated change frequency stool ; onset associated change form ( appearance ) stool Aged 18 65 year old Exclusion criterion : Other significant disease , psychological disorder , drug allergy pregnancy Taking nonsteroidal antiinflammatory drug ( NSAIDs ) , corticosteroid immunosuppressive drug precede 6 month . All drug potentially affect gastrointestinal motility sensitivity discontinue least 1 week gastric emptying study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>FODMAP</keyword>
	<keyword>Irritable bowel syndrome</keyword>
	<keyword>Gastric accommodation</keyword>
	<keyword>Gastric motility</keyword>
	<keyword>brain-gut axis</keyword>
</DOC>